Midkine expression correlating with growth activity and tooth morphogenesis in odontogenic tumors

Human Pathology

Volumn 39, Issue 5, 2008, Pages 694-700

  Fujita, Shuichi ^a   Seki, Sachiko ^b   Fujiwara, Mutsunori ^c   Ikeda, Tohru ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Epithelial mesenchymal interaction; Immunohistochemistry; Midkine; Odontogenic tumor; PCNA

Indexed keywords

MIDKINE;

AMELOBLASTOMA; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MORPHOGENESIS; ODONTOGENIC TUMOR; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; AMELOBLASTOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; ODONTOGENESIS; ODONTOGENIC TUMORS; ODONTOMA;

EID: 42649136885     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.09.014     Document Type: Article

References (34)

1. Kadomatsu K., and Muramatsu T. Midkine and pleiotrophin in neural development and cancer. Cancer Lett 204 (2004) 127-143
2. Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem (Tokyo) 132 (2002) 359-371
3. Haynes L., and Rumsby M. The pleiotropin/midkine family of cytokines: role in glial-neuronal signalling. Prog Brain Res 132 (2001) 313-324
4. Kurtz A., Schulte A.M., and Wellstein A. Pleiotrophin and midkine in normal development and tumor biology. Crit Rev Oncog 6 (1995) 151-177
5. Muramatsu T. Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation. Int J Dev Biol 37 (1993) 183-188
6. Bohlen P., and Kovesdi I. HBNF and MK, members of a novel gene family of heparin-binding proteins with potential roles in embryogenesis and brain function. Prog Growth Factor Res 3 (1991) 143-157
7. Honda M.J., Sumita Y., Kagami H., and Ueda M. Histological and immunohistochemical studies of tissue engineered odontogenesis. Arch Histol Cytol 68 (2005) 89-101
8. Morotomi T., Kawano S., Toyono T., et al. In vitro differentiation of dental epithelial progenitor cells through epithelial-mesenchymal interactions. Arch Oral Biol 50 (2005) 695-705
9. Mitsiadis T.A., Muramatsu T., Muramatsu H., and Thesleff I. Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis. J Cell Biol 129 (1995) 267-281
10. Philipsen H.P., Reichart P.A., and Slootweg P.J. Odontogenic tumours. In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics. Head and Neck Tumours (2005), IARC Press, Lyon 283-327
11. Muramatsu H., Song X.J., Koide N., et al. Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas. J Biochem (Tokyo) 119 (1996) 1171-1175
12. Ikematsu S., Yano A., Aridome K., et al. Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer 83 (2000) 701-706
13. Souttou B., Juhl H., Hackenbruck J., et al. Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors. J Natl Cancer Inst 90 (1998) 1468-1473
14. Sandra F., Harada H., Nakamura N., and Ohishi M. Midkine induced growth of ameloblastoma through MAPK and Akt pathways. Oral Oncol 40 (2004) 274-280
15. Ren Y.J., and Zhang Q.Y. Expression of midkine and its clinical significance in esophageal squamous cell carcinoma. World J Gastroenterol 12 (2006) 2006-2010
16. Wu X., Yao J., Li Q., Zheng H., and Xin Y. Expression of midkine in benign, premalignant and malignant vulvar tumors. Chin Med Sci J 17 (2002) 148-152
17. Thesleff I. Epithelial-mesenchymal signaling regulating tooth morphogenesis. J Cell Sci 116 (2003) 1647-1648
18. Ogawa T., Kapadia H., Wang B., and D'Souza R.N. Studies on Pax9-Msx1 protein interactions. Arch Oral Biol 50 (2005) 141-145
19. Sasaki T., Ito Y., Xu X., et al. LEF1 is a critical epithelial survival factor during tooth morphogenesis. Dev Biol 278 (2005) 130-143
20. Xu X., Bringas Jr. P., Soriano P., and Chai Y. PDGFR-alpha signaling is critical for tooth cusp and palate morphogenesis. Dev Dyn 232 (2005) 75-84
21. Kruzynska-Frejtag A., Wang J., Maeda M., et al. Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal interaction. Dev Dyn 229 (2004) 857-868
22. Xu X., Jeong L., Han J., Ito Y., Bringas Jr. P., and Chai Y. Developmental expression of Smad1-7 suggests critical function of TGF-beta/BMP signaling in regulating epithelial-mesenchymal interaction during tooth morphogenesis. Int J Dev Biol 47 (2003) 31-39
23. Thesleff I., Partanen A.M., and Vainio S. Epithelial-mesenchymal interactions in tooth morphogenesis: the roles of extracellular matrix, growth factors, and cell surface receptors. J Craniofac Genet Dev Biol 11 (1991) 229-237
24. Vainio S., Jalkanen M., and Thesleff I. Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme. J Cell Biol 108 (1989) 1945-1953
25. Mitsiadis T.A., Lardelli M., Lendahl U., and Thesleff I. Expression of Notch 1, 2 and 3 is regulated by epithelial-mesenchymal interactions and retinoic acid in the developing mouse tooth and associated with determination of ameloblast cell fate. J Cell Biol 130 (1995) 407-418
26. Mitsiadis T.A., Angeli I., James C., Lendahl U., and Sharpe P.T. Role of Islet1 in the patterning of murine dentition. Development 130 (2003) 4451-4460
27. Mitsiadis T.A., Henrique D., Thesleff I., and Lendahl U. Mouse serrate-1 (Jagged-1): expression in the developing tooth is regulated by epithelial-mesenchymal interactions and fibroblast growth factor-4. Development 124 (1997) 1473-1483
28. Kumamoto H., and Ooya K. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors. Oral Dis 12 (2006) 163-170
29. Zhang L., Chen X.M., Sun Z.J., Bian Z., Fan M.W., and Chen Z. Epithelial expression of SHH signaling pathway in odontogenic tumors. Oral Oncol 42 (2006) 398-408
30. Kumamoto H., Ohki K., and Ooya K. Expression of Sonic hedgehog (SHH) signaling molecules in ameloblastomas. J Oral Pathol Med 33 (2004) 185-190
31. Nagai N., Yamachika E., Nishijima K., et al. Immunohistochemical demonstration of tenascin and fibronectin in odontogenic tumours and human fetal tooth germs. Eur J Cancer B Oral Oncol 30B (1994) 191-195
32. Heikinheimo K., Happonen R.P., Miettinen P.J., and Ritvos O. Transforming growth factor beta 2 in epithelial differentiation of developing teeth and odontogenic tumors. J Clin Invest 91 (1993) 1019-1027
33. Heikinheimo K., Morgan P.R., Happonen R.P., Stenman G., and Virtanen I. Distribution of extracellular matrix proteins in odontogenic tumours and developing teeth. Virchows Arch B Cell Pathol Incl Mol Pathol 61 (1991) 101-109
34. Nadimi H., and Toto P.D. Product identification of ameloblastomas: an immunohistochemical study. J Oral Pathol 15 (1986) 439-444